Photo Credit: Burcu Elmas (pexels.com 10051526)
Targeting cytokine networks in neuroinflammatory diseases.
PMID: 39261632
Becher B, Derfuss T, Liblau R.
Nat Rev Drug Discov. 2024 Sep 11. doi: 10.1038/s41573-024-01026-y. Online ahead of print.PMID: 39261632 Review.
Targeting ROS in cancer: rationale and strategies.
PMID: 38982305
Glorieux C, Liu S, Trachootham D, Huang P.
Nat Rev Drug Discov. 2024 Aug;23(8):583-606. doi: 10.1038/s41573-024-00979-4. Epub 2024 Jul 9.PMID: 38982305 Review.
Targeting immunogenic cell stress and death for cancer therapy.
PMID: 38622310
Galluzzi L, Guilbaud E, Schmidt D, Kroemer G, Marincola FM.
Nat Rev Drug Discov. 2024 Jun;23(6):445-460. doi: 10.1038/s41573-024-00920-9. Epub 2024 Apr 15.PMID: 38622310 Free PMC article. Review.
Dr. Chen is a Senior Research Fellow and Group Leader at the UQ Frazer Institute. They lead a team under the UQ Health Research Accelerator (HERA) program to investigate T cell-mediated immunity in the contexts of vaccination, infection, and cancers.